-
Money /

Markets & Investing

The Hong Kong Investment Corporation made HK$2.34 billion in investment income in 2024, according to its annual report released in December. Photo: Jonathan Wong
Banking & finance

Hong Kong’s US$8 billion wealth fund eyes fintech, aerospace and AI for growth

The Hong Kong Investment Corporation will use the city’s advantages amid global competition, geopolitical challenges, CEO Clara Chan says.

Hong Kong stock market

Hong Kong stocks search for direction amid geopolitical concerns

Banking & finance

UBS, Citigroup, Morgan Stanley boost bonus for investment bankers by 20%

Banking & finance

Global funds, from BlackRock to Temasek, back China’s largest biotech firms

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne.

Global investors have reaped sizeable rewards from their investments in Hong Kong-listed biotech and pharmaceutical companies in the past year. Photo: Shutterstock
Global investors have reaped sizeable rewards from their investments in Hong Kong-listed biotech and pharmaceutical companies in the past year. Photo: Shutterstock
Biomedicine: Industry Trends

Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout

Latest example of Chinese drug maker acquiring equity in overseas partner shows they are becoming true development partners, analysts say.

Bonds

Hong Kong dollar and yuan bonds forecast to sustain record growth in 2026

Issuers and investors flock to Hong Kong dollar and yuan bonds, backed by deep liquidity and diverse yield curves.

Advertisement
Advertisement
Advertisement
Banking & finance

SF Holding, J&T strike US$1 billion deal as Asian e-commerce booms

The agreement will help SF Holding expand its international businesses, according to the Shenzhen-based company.

The deal will see SF Holding acquire an 8.45 per cent stake in J&T for about HK$8.3 billion. Photo: Shutterstock Images
The deal will see SF Holding acquire an 8.45 per cent stake in J&T for about HK$8.3 billion. Photo: Shutterstock Images
Banking & finance

Growth in sovereign investors’ China exposure slows amid political tensions

Inflows fall 58 per cent as sovereign wealth funds grow cautious, yet outlook signals selective opportunities ahead, experts say.

15
Made in China 2025

Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s

SciNeuro’s anti-amyloid programme is one of the firm’s key strategic research and development priorities to target the brain disease.

videocam
Made in China 2025

China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.

There were more than 400 million overweight or obese adults in China in 2021, according to a study. Photo: Getty Images
Banking & finance

TCM firms eye Hong Kong IPOs to fuel global expansion

Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.

A traditional Chinese medicine pharmacy at the Hong Kong Chinese Medicine Hospital in Tseung Kwan O. Photo: Edmond So
A traditional Chinese medicine pharmacy at the Hong Kong Chinese Medicine Hospital in Tseung Kwan O. Photo: Edmond So
IPO

3 Chinese AI, robotics stocks gain in Hong Kong debuts

Zhipu AI, Iluvatar CoreX and Edge Medical raised US$1.2 billion in their share offerings.

Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

Made in China 2025

Meow or never: China’s pudgy pets spark race for weight-loss drugs

Fosun and Huadong biotech labs eye feline obesity drugs as owners weigh cuteness against health risks.

The total pet population in China reached 430 million in 2024, with nearly one-third of urban cats classified as obese, according to the China Pet Industry Association. Photo: Shutterstock
Banking & finance

The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.

Healthcare firms now account for about a fifth of the more than 300 listing applications in the city. Photo: Shutterstock
Healthcare firms now account for about a fifth of the more than 300 listing applications in the city. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks jump into 2026 with biggest surge since May

Investors expect Beijing’s ‘policy pivot’ to continue, with a focus on demand-side stimulus and stabilising the housing market, analyst says.

IPO

Insilico Medicine leads 6 Hong Kong IPOs, capping banner fundraising year

Debutants raise total of US$899 million as exchange wraps up one of the most active months for IPOs since 2021.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Firmer yuan fuels share gains on bets Beijing will tolerate appreciation

Chinese equities edged higher on Friday, led by BYD, after the offshore yuan climbed through 7 per dollar for the first time since 2024.

The offshore yuan climbed past the key 7-per-dollar level on Thursday for the first time since September 2024. Photo: Shutterstock
The offshore yuan climbed past the key 7-per-dollar level on Thursday for the first time since September 2024. Photo: Shutterstock
China stock market

China stocks recover from early losses on cautious PBOC policy tone

Mainland stocks closed higher after paring earlier losses as investors read the central bank’s latest messaging as supportive but restrained.

Hong Kong stock market

Hong Kong stocks reverse gains as investors take profits before Christmas break

Losses in tech heavyweights like Kuaishou, Tencent and Xiaomi pull Hang Seng Index lower after advancing in the morning session.

Banking & finance

Gold takes centre stage as Hong Kong builds commodities ecosystem

Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.

Gold bricks displayed at Hong Kong Gold Exchange Chinese New Year Opening Ceremony in Sheung Wan. Photo: Edmond So
IPO

Charles Li halts Hong Kong IPO plan for Micro Connect fund under HKEX Chapter 21

Former HKEX chief shifts to private fund model after regime fails to see a successful listing in a decade, raising call for a review.

Charles Li says he will operate MCIF as a private fund and raise capital from the private sector. Photo: Jonathan Wong
Charles Li says he will operate MCIF as a private fund and raise capital from the private sector. Photo: Jonathan Wong
Banking & finance

Chinese AI, chip start-ups court global investors with Hong Kong listing plans

GigaDevice and Montage are each aiming to raise as much as US$1 billion from Hong Kong listings as early as January, report says.

Mergers & Acquisitions

Chinese brokerage CICC unveils merger details with Dongxing, Cinda

The three-way merger will create China’s fourth-largest investment bank with assets of US$128 billion.

Hong Kong stock market

Standard Chartered keeps overweight call on China stocks, flags recovery in 2026

Despite renewed ‘bubble’ talk around AI valuations after a November sell-off, Standard Chartered says the cycle is different this time.

Standard Chartered says Chinese equities are looking more compelling after a period of consolidation. Photo: Edmond So
Help preserve 120 years of quality journalism.
SUPPORT NOW